Compare
The same information, side by side.
Put two companies next to each other and see where their numbers differ.
First company
Regeneron Pharmaceuticals (REGN)
Second company
| Metric | Regeneron PharmaceuticalsREGN | Choose a second company |
|---|---|---|
| Fiscal year shown | FY2025, ended December 2025 | |
| Sector · Industry | Health care · Biotechnology | |
| $930.67Close on Nov 4, 2026 | ||
| +48.2% | ||
| +43.7% | ||
| $98.3B | ||
| $14.3B | ||
| +1.0% | ||
| $4.50B | ||
| 31.4% | ||
| $4.08B | ||
| $9.30B | ||
| $1.99B | ||
| 20.6 | ||
| 0.4% | ||
| Advanced metricsAdvanced | ||
| 9.5% | ||
| 24.9% | ||
| 28.4% | ||
| 5.8 | ||
| 0.06 | ||
| 0.10 | ||
The same numbers, side by side. StockLab doesn't rank companies or pick between them. Fiscal years can end in different months, so check the first row.